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Cardiopulmonary Exercise Testing in Vascular Surgery’Dear Editor,
We read with interest the article by Young et al. and value their
contribution to this area of clinical practice.1 We too are of the
opinion that more research in this area would be invaluable.
However, we are some what surprised regarding the assertion
that cardiopulmonary exercise testing (CPET) not be used out of
a research environment.
We agree that CPET should not be used simply to permit or deny
patients surgery but would suggest its value lies in identifying
those inwhomendovascular aneurysm repair (EVAR)may be a safer
alternative. The suggestion that decision making is solely based on
a series of measured numbers such as the anaerobic threshold or
VO2 max is incorrect. It forms a part of a comprehensive assess-
ment by both surgeon and anaesthetist prior to any decision on
subsequent management.
Although the review has highlighted the paucity of data and
limitations of CPET the deﬁciencies of other risk stratiﬁcation
methods suggested in the article have not been mentioned. Indeed
if existing methods were satisfactory then CPET would not be gain-
ing such popularity as an assessment tool. The Revised Cardiac Risk
Index (RCRI) has consistently been shown to perform poorly in
vascular patients.2 Echocardiography has not been shown to have
any value in predicting outcome and is not included in current
guidelines for routine preoperative evaluation.3 Despite this, it is
still commonly utilised by clinicians exemplifying the discrepancy
between available data and clinical practice.
The authors mention that CPET is not included in current guide-
lines for perioperative evaluation before AAA repair. We would
draw the authors attention to the AAA Quality Improvement
Program (QIP) guidance which does give mention of the utility of
CPET but does not mention RCRI, dobutamine stress echocardiog-
raphy or biochemical markers.4
We feel it is premature to limit the promising utility of CPET on
the basis of this review.References
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Dear Editor,
We are grateful for the interest in our systematic review
from Timbrell et al., who suggest that the value of CPET may
lie in identifying those in whom endovascular aneurysm repair
(EVAR) may be a safer alternative for patients with abdominal
aortic aneurysm (AAA). We disagree with this assertion, as
available data increasingly suggest that aneurysm morphology,
rather than patient physiology or comorbidity, is the stronger
predictor of long-term outcome from EVAR.1–4 Early physiolog-
ical scoring systems for open AAA repair perform with reduced
accuracy in patients selected for open repair in the endovascu-
lar era.5 While ongoing research has demonstrated the compar-
ative utility of newer scoring systems for predicting the
outcome of open AAA repair in contemporary practice,6 no
such evidence currently exists for CPET. We therefore reiterate
the conclusion that the role of CPET in determining whether
patients should undergo open repair, EVAR, or conservative
management of AAA, requires investigation in a formal
research environment, with appropriate safeguards for patient
safety.
We appreciate that CPET has its enthusiasts, but if its value is to
be better recognised and understood in vascular patients, then its
use must be investigated through well-designed research. If unitsa On behalf of Frimley Park Regional Vascular Unit.
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